RiverVest Venture Partners
Finance · Missouri, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 S Hanley Rd Ste 1850, Saint Louis, M...Phone Number
(314) 726-6700Website
www.rivervest.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
2
2
2
1
About RiverVest Venture Partners
RiverVest is a prominent venture capital firm focused on building life science companies to meet significant unmet medical needs. The firm aims to enhance patient lives, support entrepreneurs, and gain the trust of investors through its commitment to science, strategy, and innovation. RiverVest manages multiple funds and has a diverse portfolio that includes companies addressing various health challenges. Its intended clients include healthcare entrepreneurs and investors looking to make impactful contributions in the life sciences sector.Explore more
RiverVest Venture Partners Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RiverVest Venture Partners your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if RiverVest Venture Partners had a recent Job posting/layoffs
Product Launch: Get notified when RiverVest Venture Partners launches new products
Website visits: Recent activity has been detected on your website
Check out if RiverVest Venture Partners is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at RiverVest Venture Partners
Earning: See what the market has to say on RiverVest Venture Partners recently announced quarterly report
RiverVest Venture Partners, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once RiverVest Venture Partners has new funding data
Check if RiverVest Venture Partners has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at RiverVest Venture Partners
Find more new buyers
Compare Similar Companies to RiverVest Venture Partners
Compare insights from companies similar to RiverVest Venture Partners, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RiverVest Venture Partners is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
RiverVest Venture Partners is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about RiverVest Venture Partners.
RiverVest Venture Partners Tech Stack
A closer look at the technologies used by RiverVest Venture Partners
Most Recent Scoops
Left Company
Executive Move
Derek Rapp, Managing Director, has recently left the organization and now serves as Chief Operating Officer for Donald Danforth Plant Science Center.
Executive Moves, Left Company
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
RiverVest Venture Partners News & Media
Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch - HIT Consultant
Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures.OncoResponse Raises $14M; Awarded $13M in Funding
OncoResponse, a Seattle, WA-based clinical-stage biotech company, raised $14M in funding. The round was led by RiverVest Venture Partners and including ARCH Venture Partners, Canaan Partners, 3B Future Health Fund, Bering Capital, Takeda Ventures, InterVest and others. OncoResponse has also been awarded a $13M grant from the Cancer Prevention and Research Institute of Texas (CPRIT). The company intends to use […] The post OncoResponse Raises $14M; Awarded $13M in Funding appeared first on FinSMEAlleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial
AUSTIN, Texas--(BUSINESS WIRE)--Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical TrialSeQure Dx Announces $17.5M Series A Funding
WALTHAM, Mass.--(BUSINESS WIRE)--SeQure Dx, a gene-editing diagnostics company, announced today a $17.5 million Series A funding led by RiverVest Venture Partners and Mass General Brigham Ventures along with Digitalis Ventures, Casdin Capital, KdT Ventures, Bold Capital Partners and Alexandria Venture Investments. Funds will be used for initial company development leading to establishment of a full-service laboratory providing off-target gene-editing analysis for use in drug development, clinic
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RiverVest Venture Partners
Sign Up For FreeTo access detailed company insights
RiverVest is a prominent venture capital firm focused on building life science companies to meet significant unmet medical needs. The firm aims to enhance patient lives, support entrepreneurs, and gain the trust of investors through its commitment to science, strategy, and innovation. RiverVest manages multiple funds and has a diverse portfolio tha... Read More
